Page last updated: 2024-08-24

triazoles and Antibody Deficiency Syndrome

triazoles has been researched along with Antibody Deficiency Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, M; Calore, E; Carraro, F; Cesaro, S; Decembrino, N; Molinaro, M; Perruccio, K; Putti, MC; Rossin, S; Tridello, G; Vicenzi, EB1
Blanche, S; Bougnoux, ME; Elie, C; Gerin, M; Jullien, V; Lanternier, F; Lortholary, O; Mahlaoui, N1
Giles, SS; Kurtzberg, J; Perfect, JR; Schell, WA; Steinbach, WJ; Trinh, JV1

Other Studies

3 other study(ies) available for triazoles and Antibody Deficiency Syndrome

ArticleYear
Posaconazole oral dose and plasma levels in pediatric hematology-oncology patients.
    European journal of haematology, 2018, Volume: 100, Issue:3

    Topics: Administration, Oral; Adolescent; Anemia, Aplastic; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Administration Schedule; Drug Dosage Calculations; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Mycoses; Remission Induction; Retrospective Studies; Survival Analysis; Transplantation, Homologous; Triazoles

2018
Therapeutic drug monitoring of voriconazole after intravenous administration in infants and children with primary immunodeficiency.
    Therapeutic drug monitoring, 2011, Volume: 33, Issue:4

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunologic Deficiency Syndromes; Infant; Injections, Intravenous; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2011
Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy.
    Medical mycology, 2003, Volume: 41, Issue:4

    Topics: Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Brain Abscess; Brain Diseases; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Immunologic Deficiency Syndromes; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003